Educational information, not medical advice — ask your doctor or midwife.
Track Bakumondoto (Kampo) with reminders and record whether it helped, in the app.
Bakumondoto is a six-herb Kampo formula first recorded in the Chinese classic 'Jinkui Yaolue' (circa 200 CE) and refined through centuries of Japanese Kampo practice. The formula centers on Ophiopogon japonicus root, a moisture-restoring herb that forms roughly half the formula by weight, combined with supporting herbs that calm airway inflammation, tonify digestion, and moderate the formula's overall action. It became one of the most frequently prescribed Kampo formulas in Japan for respiratory complaints, and today it is a standardized prescription product widely used in Japanese clinical practice.
Bakumondoto is understood in Kampo terms as 'moistening dryness and descending rebellious lung qi' — essentially calming an overactive cough reflex and restoring moisture to irritated airways. Modern research points to several mechanisms: Ophiopogon compounds appear to suppress the cough reflex by acting on sensory nerves in the airways, and the formula as a whole has been shown to increase the production of substance P in the throat, which helps restore the swallowing reflex and protect the airway. It also has mild anti-inflammatory effects on the mucous membranes of the upper airway and esophagus.
In Japan, Bakumondoto is most commonly dispensed as a standardized granule (extract granule powder) under brand names like Tsumura TJ-29, which is used in Japanese hospitals and clinics. Traditional preparation involves simmering the six dried herbs as a decoction. Outside Japan, it is available in Chinese medicine dispensaries as a dry granule or as pre-made tablets. The granule form is convenient and the most studied in clinical trials.
The formula originates from Zhang Zhongjing's 'Jinkui Yaolue' (Essential Prescriptions of the Golden Cabinet), a foundational Chinese medical text from around 200 CE. It was adopted into Japanese Kampo medicine and has been in continuous clinical use for over 1,800 years. In modern Japan, it became one of the 148 Kampo formulas covered by national health insurance, reflecting its well-established role in clinical respiratory care. It gained renewed research interest in the 1990s–2000s when Japanese investigators began studying it for ACE-inhibitor-induced cough and aspiration pneumonia prevention in the elderly.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.